Friedrich & ClementBETA

AOK Bayern - Die Gesundheitskasse

Germany · 426 open tenders · 1,752 documented awards

Current tenders

AOK Hof - Replacement New Building - General Contractor
Deadline 7 Oct ·
AOK Hof - Replacement Building - General Contractor
8.500.000 €Deadline 7 Oct ·
AOK Hof - Replacement New Construction - General Contractor
BELOW THRESHOLDDeadline 7 Oct ·
Video consultation
Deadline 9 Oct ·
Video consultation
2.600.500 €Deadline 9 Oct ·
Contract for Call Center Services for Insured Communication Provision Contracts
Deadline 15 Oct ·
Contract for Call Center Services for Insured Communication Provision Contracts
3.108.000 €Deadline 15 Oct ·
Open house drug rebate agreements Tocilizumab, ATC L04AC07
Deadline 5 Nov ·
Open house Arzneimittelrabattverträge Lipegfilgrastim, ATC L03AA14
Deadline 5 Nov ·
Open house Pharmaceutical Rebate Agreements Lipegfilgrastim, ATC L03AA14
Deadline 5 Nov ·
Open house Tocilizumab drug discount agreements, ATC L04AC07
Deadline 5 Nov ·
Open house Pharmaceutical Discount Contracts Buserelin, ATC L02AE01
Deadline 5 Dec ·
Open house pharmaceutical discount agreements Tapentadol in non-retarded pharmaceutical forms, ATC N02AX06
Deadline 5 Dec ·
Open house pharmaceutical discount agreements Trentino, ATC A16AX12
Deadline 5 Dec ·
Open house Drug Discount Agreements Carbamazepine, ATC N03AF01
Deadline 5 Dec ·
Open house medicinal discount contracts Trentino, ATC A16AX12
Deadline 5 Dec ·
Open house Pharmaceutical Rebate Agreements Carbamazepine, ATC N03AF01
Deadline 5 Dec ·
Open house Pharmaceutical Rebate Agreements Tapentadol in non-extended-release formulations, ATC N02AX06
Deadline 5 Dec ·
Open house Pharmaceutical Discount Agreements Buserelin, ATC L02AE01
Deadline 5 Dec ·
Open house drug rebate contracts Botulinum toxin type A, finished pharmaceutical product name Xeomin(R), ATC M03AX21
Deadline 5 Jan ·
Open house Pharmaceutical Discount Agreements Goserelin, ATC L02AE03
Deadline 5 Jan ·
Open house Pharmaceutical Discount Agreements Colecalciferol, non RX, exclusively products prescribable according to Annex 1 AM-RL G-BA, ATC A11CC05
Deadline 5 Jan ·
Open house pharmaceutical discount agreements Nilotinib, ATC L01EA03 (excluding Nilotinib dispersed in applesauce, unless the manufacturer has patent protection for this)
Deadline 5 Jan ·
Open house Pharmaceutical Discount Agreements Cholecalciferol, non-prescription, exclusively products eligible for prescription according to Appendix 1 AM-RL G-BA, ATC A11CC05
Deadline 5 Jan ·
Open house Pharmaceutical Rebate Agreements Botulinum Toxin Type A, Finished Pharmaceutical Product Name Xeomin(R), ATC M03AX21
Deadline 5 Jan ·
Open house Drug Discount Agreements Goserelin, ATC L02AE03
Deadline 5 Jan ·
Open house Pharmaceutical Discount Agreements Nilotinib, ATC L01EA03 (excluding Nilotinib dispersed in applesauce, unless the manufacturer enjoys patent protection for this)
Deadline 5 Jan ·
Open house Pharmaceutical discount agreements Brinzolamide and Brimonidine, ATC S01EC24
Deadline 5 Feb ·
Open House Pharmaceutical Rebate Agreements Rotigotine, ATC N04BC09
Deadline 5 Feb ·
Open house Opipramol pharmaceutical rebate agreements, ATC N06AA05
Deadline 5 Feb ·

Purchasing rhythm

Awards per year — who knows the rhythm prepares before the notice appears.

2018179
2019278
2020375
2021209
2022239
2023345
2024551
2025624
2026366

Clement What the numbers say about this buyer

  • 72% of this buyer's awards went to companies that had already won here before (1,127 awards since 2017, spread over 321 companies). That is well above the national norm (45%) — newcomers have a harder time here than elsewhere.n = 1,127 awards since 2017
  • The median procedure drew just one bid (1,070 procedures with a bid count); 78% ended with a single bidder. Country: median 3.1 bids.n = 1,070
  • The award came in at a median 98% of the estimated value (5 awards with both estimate and value) — pricing at the estimate is usually about right here. Country: 86%.n = 5
  • From notice to award takes a median 42 days here (85 procedures). Country: 91 days.n = 85
  • Across 151 procedures with structured selection criteria, this buyer most often required: Trade register enrolment (146 of 151), References: services (5 of 151), Technical staff for execution (4 of 151), Professional liability insurance (4 of 151).n = 151
  • 66% of the bids received came from small and medium-sized enterprises (16 procedures with a bid mix). Country: 75%.n = 16
  • 0% of the bids received came from other countries (16 procedures with a bid mix) — all bidders, not just the winners. Country: 3%.n = 16

From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 04/10/2026.

Expected next awards

From the rhythm of past awards per sector — an expectation, not an announcement. Hit rate so far: 26% of 11,200 closed expectation windows produced a notice.

Who has won here before

CompanyAwardsPeriod
ratiopharm GmbH562014–2023
Hexal AG · Holzkirchen462011–2022
Aliud Pharma GmbH · Laichingen452011–2023
Haemato Pharm GmbH · Schönefeld432014–2022
Orifarm GmbH · Leverkusen392018–2023
kohlpharma GmbH · Merzig382015–2023
CC Pharma GmbH · Densborn372016–2023
axicorp Pharma B.V. · EC Den Haag362019–2023
Abacus Medicine A/S · Kopenhagen352017–2023
TAD Pharma GmbH · Cuxhaven332011–2023

From 18.0M documented awards · regular winners know this buyer's requirements — that is your competition.